Intraarticular Hyaluronic Acid Superior to Mepivacaine for Improving Pain and Function of Hip OA
Arthritis Res Ther. 2009;11(6):R183.Forty-two patients with hip osteoarthritis were randomized to receive an intra-articular injection of hyaluronic acid or local anesthetic (2% mepivacaine) for improving function and relief of pain. The primary outcome of interest was the Lequesne index. Secondary outcomes of interest include pain on a Visual Analog Scale (VAS), non-steroidal anti-inflammatory drug consumption, global physician assessment, and global patient assessment. Outcomes were assessed at 3- and 6- months post-injection. Study results revealed significantly favourable Lequesne index scores and VAS pain scores in the hyaluronic acid group compared to the mepivacaine group, at both 3- and 6-months post-injection. Otherwise, no significant differences were observed between the two groups.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
